CEACAM5 and gastric cancer: These markers have been used for the prediction of prognosis and recurrences of GC after surgery.[5–9] However, rare studies have been focused on the evaluation of the prognostic significance of serum CEA and CA19-9 levels within 4 weeks after curative resection.